The suppliers of FB3, a new herbal-based weight-management ingredient introduced earlier this year, have created a new beverage with the ingredient, called FB3 Fusion.
The suppliers of FB3, a new herbal-based weight-management ingredient introduced earlier this year, have created a new beverage with the ingredient, called FB3 Fusion.
“In addition to our FB3 tablets, the interest in foods and beverages containing healthy ingredients has led to [the] development of [the] FB3 Fusion Ingredient in the form of [an] on-the-go shot drink with pomegranate in a 50-ml serving size,” said Vladimir Badmaev, MD, PhD, CEO of American Medical Holdings (New York City), which launched FB3 together with supplier Bio Actives Japan (Tokyo).
FB3 is said to present an alternative to conventional fat blockers. Based on three herbal ingredients-Coleus forskohlii, Salacia reticulata, and Sesamum indicum-the ingredient’s pathway of operation is by inhibiting pancreatic lipase. Unlike other fat blockers, it avoids “negative gastrointestinal and metabolic side effects,” the companies have said, citing in vitro data.
The company says its research showed that FB3 prevented absorption of omega-6 fatty acids and dietary fat. “Hypothetically,” it said via press release, “preventing absorption of excess dietary fat and omega-3 fatty acids may gradually normalize the overactive endocannabinoid system, thereby preventing obesity, especially if this approach is combined with consuming an omega-3 fatty acid-rich diet, which competes with omega-6 fatty acid absorption.”
Also read:
Fusion Ingredient Inhibits Fat Absorption-without Side Effects?
The impact of GLP-1 on supplements, functional foods, and retail: a webinar from CRN
January 29th 2025The recent CRN webinar discussed GLP-1 medications' impact on supplements, functional foods, and retail, covering consumer trends, global market insights, retailer strategies, industry implications, and future opportunities for innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.